• OPEN AN ACCOUNT
Indian Indices
Nifty
24,631.30 11.95
(0.05%)
Sensex
80,597.66 57.75
( 0.07%)
Bank Nifty
55,341.85 160.40
( 0.29%)
Nifty IT
34,833.20 140.25
( 0.40%)
Global Indices
Nasdaq
44,917.96 438.34
(0.99%)
Dow Jones
6,479.45 12.69
(0.20%)
Hang Seng
42,649.26 -625.41
(-1.45%)
Nikkei 225
9,165.23 17.42
(0.19%)
Forex
USD-INR
87.63 0.02
(0.02%)
EUR-INR
102.01 0.08
(0.08%)
GBP-INR
118.04 0.28
(0.24%)
JPY-INR
0.59 0.00
(-0.19%)

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524632
INE551C01044
1.4350513
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
83.23
801.76
EPS(TTM)
Face Value()
Div & Yield %
0.22
1
0
 

As on: Aug 14, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
17.95 -0.36 21428 83.23
Stock Price Details
Open Price() 17.95
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 17.95
Today's Low () 17.95
52-Week High () 27.15
152-Week Low () 5.75
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 0.22
Book Value 1.4350513
Market Cap (.Cr) 801.76
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE551C01044


News
Shukra Pharmaceuticals standalone net profit rises 110.20% in the June 2025 quarter
Shukra Pharmaceuticals Ltd - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Wednesday August 13 2025.
Shukra Pharmaceuticals Ltd - Un-Audited Financial Results Of The Company For The First Quarter Ended June 30 2025 Along With The Auditors Limited Review Reports In Accordance With The Provisions Of Regulation 33 Of The SEBI Listing Regulations.
Shukra Pharmaceuticals announces board meeting date
Shukra Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Shukra Pharmaceuticals Ltd - Grant Of Distributorship Rights
Shukra Pharmaceuticals Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Shukra Pharmaceuticals Ltd - Closure of Trading Window
Shukra Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Board of Shukra Pharmaceuticals recommends Final Dividend
More
Corporate Details
Incoporation Year   : 1993
Chairman : Dakshesh Shah
Bussiness Group :
Registered Office
Shukra Pharmaceuticals Ltd
3 rd Floor Dev House,
Opp WIAA Office Judges Bungalo,
Ahmedabad,
Gujarat-380054
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-079-66522247/27498515
Fax:N.A.
Fax:91-22-66317458
E-Mail : info@shukrapharmaceuticals.com
URL : http://www.shukrapharmaceuticals.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
No Data Found...!
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi